DES Strut Thickness and Clinical Outcomes After CTO Recanalization: Insights From LATAM CTO Registry

Câmara, Sérgio F.; Campos, Carlos M.; Machado, Rodrigo D.; Padilla, Lucio; Tinôco, João Maria de Lima; Botelho, Antonio Carlos; Santiago, Ricardo; Echavarria, Mauro; Santos, Félix Damas de los; Oliveira, Marcos Danillo Peixoto; Abelin, Aníbal P.; Pino, Luis P.; Oliveira, Pedro Piccaro de; Ribeiro, Marcelo Harada; Brilakis, Emmanouil S.; Abizaid, Alexandre; Quadros, Alexandre Schaan de

doi:10.1016/j.carrev.2023.03.002

Cardiovascular Revascularization Medicine

2023

DOI: 10.1016/j.carrev.2023.03.002

|View full text |Cite

DES Strut Thickness and Clinical Outcomes After CTO Recanalization: Insights From LATAM CTO Registry

Sérgio F. Câmara¹,

Carlos M. Campos²,

Rodrigo D. Machado³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Long‐Term Clinical Outcomes of Biodegradable‐ Versus Durable‐Polymer‐Coated Everolimus‐Eluting Stents in Real‐World Post‐Marketing Study

Abusnina,

Case,

Zhang

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

BackgroundLong‐term clinical data on biodegradable‐polymer (BP) drug‐eluting stents (DES) are limited. The objective of this study was to assess the long‐term safety and efficacy of the BP‐DES SYNERGY compared to XIENCE V, a durable‐polymer (DP)‐DES.MethodsWe compared patients treated with BP‐DES or DP‐DES at our center from 2008 to 2020. The primary outcome was major adverse cardiac events (MACE), defined as the composite of all‐cause death, Q‐wave myocardial infarction (MI), and target vessel revascularization (TVR). Secondary endpoints were all‐cause death, Q‐wave MI, target lesion revascularization (TLR), and stent thrombosis (ST).ResultsA total of 4255 patients underwent propensity‐score matching, and 380 patients from each cohort were matched. There was no significant difference between BP‐DES and DP‐DES concerning MACE (5‐year estimates: 21.6% vs. 26.6%, log‐rank p = 0.259). Furthermore, there was no difference in the TLR rate (5‐year estimates: 7.3% vs. 8.6%, log‐rank p = 0.781). All‐cause death (5‐year estimates: 13.6% vs. 12.9%, log‐rank p = 0.72) and Q‐wave MI (5‐year estimates: 0.53% vs. 1.7%, log‐rank p = 0.427) were also comparable between the two groups. Of note, the rate of very late ST was very low and similar between the groups (5‐year estimates: 0.26% vs. 0.64%, log‐rank p = 0.698).ConclusionBP‐DES and DP‐DES demonstrate similar safety and efficacy at 5‐year follow‐up. Both can be used for the effective treatment of coronary artery disease.

show abstract

Long‐Term Clinical Outcomes of Biodegradable‐ Versus Durable‐Polymer‐Coated Everolimus‐Eluting Stents in Real‐World Post‐Marketing Study

Abusnina,

Case,

Zhang

et al. 2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

Editorial: Stent Strut Thickness and Outcome in Chronic Total Coronary Occlusions: The Thinner the Better?

Werner

Yaginuma

2023

Cardiovascular Revascularization Medicine

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

DES Strut Thickness and Clinical Outcomes After CTO Recanalization: Insights From LATAM CTO Registry

Cited by 2 publications

References 14 publications

Long‐Term Clinical Outcomes of Biodegradable‐ Versus Durable‐Polymer‐Coated Everolimus‐Eluting Stents in Real‐World Post‐Marketing Study

Long‐Term Clinical Outcomes of Biodegradable‐ Versus Durable‐Polymer‐Coated Everolimus‐Eluting Stents in Real‐World Post‐Marketing Study

Editorial: Stent Strut Thickness and Outcome in Chronic Total Coronary Occlusions: The Thinner the Better?

Contact Info

Product

Resources

About